Trial intelligence / Profile preview

Hydromorphone vs Piritramide for Pain After Shoulder Surgery

NCT03541759Phase 4Completed

Sponsor
AUVA-Traumazentrum Wien, Standort Meidling
Start
Jan 2018
Primary completion
May 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, open-label trial in postoperative pain comparing Hydromorphone with Piritramide (2 arms). Primary endpoint: Pain management after elective shoulder surgery at 6 months. Started Jan 2018; status: completed.

02

Drugs

hydromorphonepiritramide
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03541759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03541759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call